Key points
Building up the preclinical proof of concept package for Nuvec®: Focus on building out the
dataset and to secure commercial partnerships. As a delivery system which aims to improve nucleic acid delivery, Nuvec® is well-positioned to capture interest in this growing area.
N4-101 for Inflammatory Bowel Disease (IBD): Positive results from in vivo proof-of
concept project showing a decrease in inflammation and other disease biomarkers.
Expanding the leadership team: Alastair Smi ....
